Skip to Content

Notice

Importer of Controlled Substances Registration: United States Pharmacopeial Convention

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

ACTION:

Notice of registration.

SUMMARY:

United States Pharmacopeial Convention applied to be registered as an importer of certain basic classes of controlled substances. The DEA grants United States Pharmacopeial Convention registration as an importer of those controlled substances.

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

By notice dated August 11, 2014, and published in the Federal Register on August 20, 2014, 79 FR 49341, United States Pharmacopeial Convention, 12601 Twinbrook Parkway, Rockville, Maryland 20852, applied to be registered as an importer of certain basic classes of controlled substances. No Start Printed Page 8903comments or objections were submitted to this notice.

The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of United States Pharmacopeial Convention to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.

Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above-named company is granted registration as an importer of the basic classes of controlled substances listed:

Controlled substanceSchedule
Cathinone (1235)I
Methaqualone (2565)I
Lysergic acid diethylamide (7315)I
Marihuana (7360)I
Tetrahydrocannabinols (7370)I
4-Methyl-2,5-dimethoxyamphetamine (7395)I
3,4-Methylenedioxyamphetamine (7400)I
Codeine-N-oxide (9053)I
Difenoxin (9168)I
Heroin (9200)I
Morphine-N-oxide (9307)I
Norlevorphanol (9634)I
Amphetamine (1100)II
Methamphetamine (1105)II
Phenmetrazine (1631)II
Methylphenidate (1724)II
Amobarbital (2125)II
Pentobarbital (2270)II
Secobarbital (2315)II
Glutethimide (2550)II
Phencyclidine (7471)II
4-Anilino-N-phenethyl-4-piperidine (8333)II
Phenylacetone (8501)II
Alphaprodine (9010)II
Anileridine (9020)II
Cocaine (9041)II
Codeine (9050)II
Dihydrocodeine (9120)II
Oxycodone (9143)II
Hydromorphone (9150)II
Diphenoxylate (9170)II
Hydrocodone (9193)II
Levomethorphan (9210)II
Levorphanol (9220)II
Meperidine (9230)II
Methadone (9250)II
Dextropropoxyphene, bulk (non-dosage forms) (9273)II
Morphine (9300)II
Thebaine (9333)II
Oxymorphone (9652)II
Noroxymorphone (9668)II
Alfentanil (9737)II
Sufentanil (9740)II

The company plans to import reference standards for sale to researchers and analytical labs.

The company plans to import the listed controlled substances in bulk powder form from foreign sources for the manufacture of analytical reference standards for sale to their customers.

Start Signature

Dated: February 11, 2015.

Joseph T. Rannazzisi,

Deputy Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2015-03481 Filed 2-18-15; 8:45 am]

BILLING CODE 4410-09-P